PAMU
ALXO icon

Pictet Asset Management (UK)’s ALX Oncology ALXO Stock Holding History

Pictet Asset Management (UK)’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$23.1M Buy
421,932
+2,039
+0.5% +$122K 0.03% 495
2021
Q1 		$31M Sell
419,893
-7,067
-2% -$556K 0.04% 421
2020
Q4 		$36.8M Buy
+426,960
New +$25.7M 0.05% 366

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Pictet Asset Management (UK)'s ALXO Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its ALX Oncology (ALXO) stake by 0.49% in Q2 2021, buying an estimated $122K and bringing the position to 421,932 shares worth $23.1M. The position accounts for 0.03% of the portfolio, ranked #495.

Pictet Asset Management (UK) first reported a position in ALXO in Q4 2020 and has held it in 3 quarters since. The position peaked at $36.8M in Q4 2020. 104 funds tracked by Wall St. Rank hold ALXO as of Q2 2021.

  • Pictet Asset Management (UK) held 421,932 shares of ALX Oncology worth $23.1M as of Q2 2021.
  • Pictet Asset Management (UK) bought 2,039 ALX Oncology shares in Q2 2021, an estimated $122K.
  • ALX Oncology made up 0.03% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #495 holding.
  • Pictet Asset Management (UK) first reported a position in ALX Oncology in Q4 2020 and has held it in 3 quarters since.
  • Pictet Asset Management (UK)'s ALX Oncology position peaked at $36.8M in Q4 2020.
  • 104 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.